References

Adams, J. M., Difazio, L. T., Rolandelli, R. H., Lujan, J. J., Hasko, G., Csoka, B., Selmeczy, Z., and Nemeth, Z. H. (2009). HIF-1: a key mediator in hypoxia. Acta Physiol. Hung. 96, 19–28.
| CrossRef | CAS | PubMed |

Ahluwalia, A., and Tarnawski, A. S. (2004). Critical role of hypoxia sensor HIF-1alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr. Med. Chem. 19, 90–97.

Alam, H., Maizels, E. T., Park, Y., Ghaey, S., Feiger, Z. J., Chandel, N. S., and Hunzicker-Dunn, M. (2004). Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J. Biol. Chem. 279, 19 431–19 440.
| CrossRef | CAS |

Alam, H., Weck, J., Maizels, E., Park, Y., Lee, E. J., Ashcroft, M., and Hunzicker-Dunn, M. (2009). Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone. Endocrinology 150, 915–928.
| CrossRef | CAS | PubMed |

Basini, G., Baioni, L., Bussolati, S., Grolli, S., Kramer, L. H., Wagner, G. F., and Grasselli, F. (2010). Expression and localization of stanniocalcin 1 in swine ovary. Gen. Comp. Endocrinol. 166, 404–408.
| CrossRef | CAS | PubMed |

Ben-Yosef, Y., Lahat, N., Shapiro, S., Bitterman, H., and Miller, A. (2002). Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ. Res. 90, 784–791.
| CrossRef | CAS | PubMed |

Berisha, B., and Schams, D. (2005). Ovarian function in ruminants. Domest. Anim. Endocrinol. 29, 305–317.
| CrossRef | CAS | PubMed |

Berisha, B., Schams, D., Kosmann, M., Amselgruber, W., and Einspanier, R. (2000a). Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles. J. Endocrinol. 167, 371–382.
| CrossRef | CAS | PubMed |

Berisha, B., Schams, D., Kosmann, M., Amselgruber, W., and Einspanier, R. (2000b). Expression and tissue concentration of vascular endothelial growth factor, its receptors and localization in the bovine corpus luteum during oestrous cycle and pregnancy. Biol. Reprod. 63, 1106–1114.
| CrossRef | CAS | PubMed |

Boonyaprakob, U., Gadsby, J. E., Hedgpeth, V., Routh, P. A., and Almond, G. W. (2005). Expression and localization of hypoxia inducible factor-1 alpha mRNA in the porcine ovary. Can. J. Vet. Res. 69, 215–222.
| CAS | PubMed |

Brahimi-Horn, M. C., and Pouyssegur, J. (2009). HIF at a glance. J. Cell Sci. 122, 1055–1057.
| CrossRef | CAS | PubMed |

Brouillet, S., Hoffmann, P., Chauvet, S., Salomon, A., Chamboredon, S., Sergent, F., Benharouga, M., Feige, J. J., and Alfaidy, N. (2012). Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors. Cell. Mol. Life Sci. 69, 1537–1550.
| CrossRef | CAS | PubMed |

Calvani, M., Rapisarda, A., Uranchimeg, B., Shoemaker, R. H., and Melillo, G. (2006). Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107, 2705–2712.
| CrossRef | CAS | PubMed |

Chen, T. H., Wang, J. F., Chan, P., and Lee, H. M. (2005). Angiotensin II stimulates hypoxia-inducible factor 1 alpha accumulation in glomerular mesangial cells. Ann. N. Y. Acad. Sci. 1042, 286–293.
| CrossRef | CAS | PubMed |

Clerici, C., and Planes, C. (2009). Gene regulation in the adaptive process to hypoxia in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L267–L274.
| CrossRef | CAS | PubMed |

Crews, S. T. (1998). Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev. 12, 607–620.
| CrossRef | CAS | PubMed |

Duncan, W. C., van den Driesche, S., and Fraser, H. M. (2008). Inhibition of vascular endothelial growth factor in the primate ovary upregulates hypoxia-inducible factor-1 alpha in the follicle and corpus luteum. Endocrinology 149, 3313–3320.
| CrossRef | CAS | PubMed |

Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O’Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., Tian, Y. M., Masson, N., Hamilton, D. L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P. H., Pugh, C. W., Schofield, C. J., and Ratcliffe, P. J. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54.
| CrossRef | CAS | PubMed |

Ferrara, N., and Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4–25.
| CrossRef | CAS | PubMed |

Ferrara, N., LeCouter, J., Lin, R., and Peale, F. (2004). EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors. Biochim. Biophys. Acta 1654, 69–78.
| CAS | PubMed |

Fraser, H. M. (2006). Regulation of the ovarian follicular vasculature. Reprod. Biol. Endocrinol. 4, 18.
| CrossRef | PubMed |

Fraser, H. M., and Lunn, S. F. (2001). Regulation and manipulation of angiogenesis in the primate corpus luteum. Reproduction 121, 355–362.
| CrossRef | CAS | PubMed |

Fraser, H. M., Morris, K. D., Wiegand, S. J., and Wilson, H. (2010). Inhibition of vascular endothelial growth factor during the postovulatory period prevents pregnancy in the marmoset. Contraception 82, 572–578.
| CrossRef | CAS | PubMed |

Gabler, C., Plath-Gabler, A., Killian, G. J., Berisha, B., and Schams, D. (2004). Expression pattern of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) system members in bovine corpus luteum endothelial cells during treatment with FGF-2, VEGF or oestradiol. Reprod. Domest. Anim. 39, 321–327.
| CrossRef | CAS | PubMed |

Gerber, H. P., Condorelli, F., Park, J., and Ferrara, N. (1997). Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is upregulated by hypoxia. J. Biol. Chem. 272, 23 659–23 667.
| CrossRef | CAS |

Giordano, F. J., and Johnson, R. S. (2001). Angiogenesis: the role of the microenvironment in flipping the switch. Curr. Opin. Genet. Dev. 11, 35–40.
| CrossRef | CAS | PubMed |

Gospodarowicz, D., Cheng, J., Lui, G. M., Baird, A., Esch, F., and Bohlen, P. (1985). Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 117, 2383–2391.
| CrossRef | CAS | PubMed |

Groulx, I., and Lee, S. (2002). Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel–Lindau tumour suppressor protein. Mol. Cell. Biol. 22, 5319–5336.
| CrossRef | CAS | PubMed |

Guilini, C., Urayama, K., Turkeri, G., Dedeoglu, D. B., Kurose, H., Messaddeq, N., and Nebigil, C. G. (2010). Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration. Am. J. Physiol. Heart Circ. Physiol. 298, H844–H852.
| CrossRef | CAS | PubMed |

Han, Z. B., Ren, H., Zhao, H., Chi, Y., Chen, K., Zhou, B., Liu, Y. J., Zhang, L., Xu, B., Liu, B., Yang, R., and Han, Z. C. (2008). Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 29, 1853–1861.
| CrossRef | CAS | PubMed |

Hazzard, T. M., Molskness, T. A., Chaffin, C. L., and Stouffer, R. L. (1999). Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol. Hum. Reprod. 5, 1115–1121.
| CrossRef | CAS | PubMed |

He, L. F., Wang, T. T., Gao, Q. Y., Zhao, G. F., Huang, Y. H., Yu, L. K., and Hou, Y. Y. (2011). Stanniocalcin-1 promotes tumour angiogenesis through upregulation of VEGF in gastric cancer cells. J. Biomed. Sci. 18, 39.
| CrossRef | CAS | PubMed |

Hewitson, K. S., Schofield, C. J., and Ratcliffe, P. J. (2007). Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2. Methods Enzymol. 435, 25–42.
| CrossRef | CAS | PubMed |

Huang, L. E., Arany, Z., Livingston, D. M., and Bunn, H. F. (1996). Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271, 32 253–32 259.
| CrossRef | CAS |

Jiang, B. H., Rue, E., Wang, G. L., Roe, R., and Semenza, G. L. (1996). Dimerization, DNA binding and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17 771–17 778.
| CrossRef | CAS |

Jiang, Y. F., Tsui, K. H., Wang, P. H., Lin, C. W., Wang, J. Y., Hsu, M. C., Chen, Y. C., and Chiu, C. H. (2011). Hypoxia regulates cell proliferation and steroidogenesis through protein kinase A signalling in bovine corpus luteum. Anim. Reprod. Sci. 129, 152–161.
| CrossRef | CAS | PubMed |

Kaczmarek, M. M., Schams, D., and Ziecik, A. J. (2005). Role of vascular endothelial growth factor in ovarian physiology – an overview. Reprod. Biol. 5, 111–136.
| PubMed |

Kallio, P. J., Pongratz, I., Gradin, K., McGuire, J., and Poellinger, L. (1997). Activation of hypoxia-inducible factor 1 alpha: post-transcriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl. Acad. Sci. USA 94, 5667–5672.
| CrossRef | CAS | PubMed |

Kallio, P. J., Wilson, W. J., O’Brien, S., Makino, Y., and Poellinger, L. (1999). Regulation of the hypoxia-inducible transcription factor 1 alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519–6525.
| CrossRef | CAS | PubMed |

Kietzmann, T., Roth, U., and Jungermann, K. (1999). Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94, 4177–4185.
| CAS | PubMed |

Kim, M. R., Choi, H. S., Heo, T. H., Hwang, S. W., and Kang, K. W. (2008). Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells. Biochem. Biophys. Res. Commun. 369, 547–553.
| CrossRef | CAS | PubMed |

Kim, J., Bagchi, I. C., and Bagchi, M. K. (2009). Signalling by hypoxia-inducible factors is critical for ovulation in mice. Endocrinology 150, 3392–3400.
| CrossRef | CAS | PubMed |

Kisliouk, T., Levy, N., Hurwitz, A., and Meidan, R. (2003). Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. J. Clin. Endocrinol. Metab. 88, 3700–3707.
| CrossRef | CAS | PubMed |

Kisliouk, T., Podlovni, H., and Meidan, R. (2005). Unique expression and regulatory mechanisms of EG-VEGF/prokineticin-1 and its receptors in the corpus luteum. Ann. Anat. 187, 529–537.
| CrossRef | CAS | PubMed |

Klipper, E., Levit, A., Mastich, Y., Berisha, B., Schams, D., and Meidan, R. (2010). Induction of endothelin-2 expression by luteinizing hormone and hypoxia: possible role in bovine corpus luteum formation. Endocrinology 151, 1914–1922.
| CrossRef | CAS | PubMed |

Ko, C., Gieske, M. C., Al-Alem, L., Hahn, Y., Su, W., Gong, M. C., Iglarz, M., and Koo, Y. (2006). Endothelin-2 in ovarian follicle rupture. Endocrinology 147, 1770–1779.
| CrossRef | CAS | PubMed |

Lecouter, J., Lin, R., and Ferrara, N. (2004). EG-VEGF: a novel mediator of endocrine-specific angiogenesis, endothelial phenotype and function. Ann. N. Y. Acad. Sci. 1014, 50–57.
| CrossRef | CAS | PubMed |

Lee, A., Christenson, L. K., Patton, P. E., Burry, K. A., and Stouffer, R. L. (1997a). Vascular endothelial growth factor production by human luteinized granulosa cells in vitro. Hum. Reprod. 12, 2756–2761.
| CrossRef | CAS | PubMed |

Lee, P. J., Jiang, B. H., Chin, B. Y., Iyer, N. V., Alam, J., Semenza, G. L., and Choi, A. M. (1997b). Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272, 5375–5381.
| CrossRef | CAS | PubMed |

Levy, N. S., Chung, S., Furneaux, H., and Levy, A. P. (1998). Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273, 6417–6423.
| CrossRef | CAS | PubMed |

Maeda, M., Hasebe, Y., Egawa, K., Shibanuma, M., and Nose, K. (2006). Inhibition of angiogenesis and HIF-1alpha activity by antimycin A1. Biol. Pharm. Bull. 29, 1344–1348.
| CrossRef | CAS | PubMed |

Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., Garcia, J. G., and Semenza, G. L. (2005). Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105, 659–669.
| CrossRef | CAS | PubMed |

Melillo, G., Musso, T., Sica, A., Taylor, L. S., Cox, G. W., and Varesio, L. (1995). A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683–1693.
| CrossRef | CAS | PubMed |

Na, G., Bridges, P. J., Koo, Y., and Ko, C. (2008). Role of hypoxia in the regulation of periovulatory EDN2 expression in the mouse. Can. J. Physiol. Pharmacol. 86, 310–319.
| CrossRef | CAS | PubMed |

Nakayama, K. (2009). Cellular signal transduction of the hypoxia response. J. Biochem. 146, 757–765.
| CrossRef | CAS | PubMed |

Neeman, M., Abramovitch, R., Schiffenbauer, Y. S., and Tempel, C. (1997). Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int. J. Exp. Pathol. 78, 57–70.
| CrossRef | CAS | PubMed |

Neulen, J., Yan, Z., Raczek, S., Weindel, K., Keck, C., Weich, H. A., Marme, D., and Breckwoldt, M. (1995). Human chorionic gonadotrophin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab. 80, 1967–1971.
| CrossRef | CAS | PubMed |

Nishimura, R., and Okuda, K. (2010). Hypoxia is important for establishing vascularization during corpus luteum formation in cattle. J. Reprod. Dev. 56, 110–116.
| CrossRef | CAS | PubMed |

Podlovni, H., Ovadia, O., Kisliouk, T., Klipper, E., Zhou, Q. Y., Friedman, A., Alfaidy, N., and Meidan, R. (2006). Differential expression of prokineticin receptors by endothelial cells derived from different vascular beds: a physiological basis for distinct endothelial function. Cell. Physiol. Biochem. 18, 315–326.
| CrossRef | CAS | PubMed |

Poulaki, V., Joussen, A. M., Mitsiades, N., Mitsiades, C. S., Iliaki, E. F., and Adamis, A. P. (2004). Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am. J. Pathol. 165, 457–469.
| CrossRef | CAS | PubMed |

Pugh, C. W., and Ratcliffe, P. J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677–684.
| CrossRef | CAS | PubMed |

Redmer, D. A., Doraiswamy, V., Bortnem, B. J., Fisher, K., Jablonka-Shariff, A., Grazul-Bilska, A. T., and Reynolds, L. P. (2001). Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum. Biol. Reprod. 65, 879–889.
| CrossRef | CAS | PubMed |

Reynolds, L. P., and Redmer, D. A. (1999). Growth and development of the corpus luteum. J. Reprod. Fertil. Suppl. 54, 181–191.
| CAS | PubMed |

Reynolds, L. P., Grazul-Bilska, A. T., and Redmer, D. A. (2000). Angiogenesis in the corpus luteum. Endocrine 12, 1–9.
| CrossRef | CAS | PubMed |

Richard, D. E., Berra, E., and Pouyssegur, J. (1999). Angiogenesis: how a tumour adapts to hypoxia. Biochem. Biophys. Res. Commun. 266, 718–722.
| CrossRef | CAS | PubMed |

Robinson, R. S., Nicklin, L. T., Hammond, A. J., Schams, D., Hunter, M. G., and Mann, G. E. (2007). Fibroblast growth factor 2 is more dynamic than vascular endothelial growth factor A during the follicle–luteal transition in the cow. Biol. Reprod. 77, 28–36.
| CrossRef | CAS | PubMed |

Robinson, R. S., Woad, K. J., Hammond, A. J., Laird, M., Hunter, M. G., and Mann, G. E. (2009). Angiogenesis and vascular function in the ovary. Reproduction 138, 869–881.
| CrossRef | CAS | PubMed |

Robker, R. L., Russell, D. L., Yoshioka, S., Sharma, S. C., Lydon, J. P., O’Malley, B. W., Espey, L. L., and Richards, J. S. (2000). Ovulation: a multi-gene, multi-step process. Steroids 65, 559–570.
| CrossRef | CAS | PubMed |

Sandau, K. B., Faus, H. G., and Brune, B. (2000). Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI-3K pathway. Biochem. Biophys. Res. Commun. 278, 263–267.
| CrossRef | CAS | PubMed |

Semenza, G. L. (2000). HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev. 19, 59–65.
| CrossRef | CAS | PubMed |

Semenza, G. L. (2007). Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, cm8.
| CrossRef | PubMed |

Semenza, G. L., Rue, E. A., Iyer, N. V., Pang, M. G., and Kearns, W. G. (1996). Assignment of the hypoxia-inducible factor 1 alpha gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q. Genomics 34, 437–439.
| CrossRef | CAS | PubMed |

Shi, D. Y., Xie, F. Z., Zhai, C., Stern, J. S., Liu, Y., and Liu, S. L. (2009). The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells. Mol. Cancer 8, 32.
| CrossRef | PubMed |

Singh, N., Sharma, G., and Mishra, V. (2012). Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell. Mol. Neurobiol. 32, 491–507.
| CrossRef | CAS | PubMed |

Smith, M. F., McIntush, E. W., Ricke, W. A., Kojima, F. N., and Smith, G. W. (1999). Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function. J. Reprod. Fertil. Suppl. 54, 367–381.
| CAS | PubMed |

Stein, I., Itin, A., Einat, P., Skaliter, R., Grossman, Z., and Keshet, E. (1998). Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell. Biol. 18, 3112–3119.
| CAS | PubMed |

Takahashi, Y., Takahashi, S., Shiga, Y., Yoshimi, T., and Miura, T. (2000). Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J. Biol. Chem. 275, 14 139–14 146.
| CrossRef | CAS |

Tam, K. K., Russell, D. L., Peet, D. J., Bracken, C. P., Rodgers, R. J., Thompson, J. G., and Kind, K. L. (2010). Hormonally regulated follicle differentiation and luteinization in the mouse is associated with hypoxia-inducible factor activity. Mol. Cell. Endocrinol. 327, 47–55.
| CrossRef | CAS | PubMed |

Tesone, M., Stouffer, R. L., Borman, S. M., Hennebold, J. D., and Molskness, T. A. (2005). Vascular endothelial growth factor (VEGF) production by the monkey corpus luteum during the menstrual cycle: isoform-selective messenger RNA expression in vivo and hypoxia-regulated protein secretion in vitro. Biol. Reprod. 73, 927–934.
| CrossRef | CAS | PubMed |

Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Monthouel-Kartmann, M. N., and Van Obberghen, E. (2005). Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. Mol. Endocrinol. 19, 1304–1317.
| CrossRef | CAS | PubMed |

van den Driesche, S., Myers, M., Gay, E., Thong, K. J., and Duncan, W. C. (2008). HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum. Mol. Hum. Reprod. 14, 455–464.
| CrossRef | CAS | PubMed |

Varghese, R., Wong, C. K., Deol, H., Wagner, G. F., and DiMattia, G. E. (1998). Comparative analysis of mammalian stanniocalcin genes. Endocrinology 139, 4714–4725.
| CrossRef | CAS | PubMed |

Waltenberger, J., Mayr, U., Pentz, S., and Hombach, V. (1996). Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94, 1647–1654.
| CrossRef | CAS | PubMed |

Wang, G. L., and Semenza, G. L. (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82, 3610–3615.
| CAS | PubMed |

Wang, G. L., and Semenza, G. L. (1995). Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230–1237.
| CrossRef | CAS | PubMed |

Wang, M. T., Honn, K. V., and Nie, D. (2007). Cyclooxygenases, prostanoids and tumour progression. Cancer Metastasis Rev. 26, 525–534.
| CrossRef | CAS | PubMed |

Wang, K., Jiang, Y. Z., Chen, D. B., and Zheng, J. (2009). Hypoxia enhances FGF-2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways. Placenta 30, 1045–1051.
| CrossRef | CAS | PubMed |

Woad, K. J., Hammond, A. J., Hunter, M., Mann, G. E., Hunter, M. G., and Robinson, R. S. (2009). FGF-2 is crucial for the development of bovine luteal endothelial networks in vitro. Reproduction 138, 581–588.
| CrossRef | CAS | PubMed |

Woad, K. J., Hunter, M. G., Mann, G. E., Laird, M., Hammond, A. J., and Robinson, R. S. (2012). Fibroblast growth factor 2 is a key determinant of vascular sprouting during bovine luteal angiogenesis. Reproduction 143, 35–43.
| CrossRef | CAS | PubMed |

Wulff, C., Wilson, H., Largue, P., Duncan, W. C., Armstrong, D. G., and Fraser, H. M. (2000). Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J. Clin. Endocrinol. Metab. 85, 4302–4309.
| CrossRef | CAS | PubMed |

Wulff, C., Wiegand, S. J., Saunders, P. T., Scobie, G. A., and Fraser, H. M. (2001). Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)). Endocrinology 142, 3244–3254.
| CrossRef | CAS | PubMed |

Yamashita, H., Kamada, D., Shirasuna, K., Matsui, M., Shimizu, T., Kida, K., Berisha, B., Schams, D., and Miyamoto, A. (2008). Effect of local neutralization of basic fibroblast growth factor or vascular endothelial growth factor by a specific antibody on the development of the corpus luteum in the cow. Mol. Reprod. Dev. 75, 1449–1456.
| CrossRef | CAS | PubMed |

Young, R. M., Wang, S. J., Gordan, J. D., Ji, X., Liebhaber, S. A., and Simon, M. C. (2008). Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism. J. Biol. Chem. 283, 16 309–16 319.
| CrossRef | CAS |

Zalman, Y., Klipper, E., Farberov, S., Mondal, M., Wee, G., Folger, J. K., Smith, G. W., and Meidan, R. (2012a). Regulation of angiogenesis-related prostaglandin f2alpha-induced genes in the bovine corpus luteum. Biol. Reprod. 86, 92.
| CrossRef | PubMed |

Zalman, Y., Yalu, R., Klipper, E., and Meidan, R. (2012b) Pleiotropic effects of FGF-2 in cells of the developing corpus luteum. In ‘Proceedings of the 41st Annual Meeting of the Israel Endocrine Society’. (Israel Endocrine Society: Tel Aviv.)

Zhang, Z., Yin, D., and Wang, Z. (2011). Contribution of hypoxia-inducible factor-1 alpha to transcriptional regulation of vascular endothelial growth factor in bovine developing luteal cells. Anim. Sci. J. 82, 244–250.
| CrossRef | CAS | PubMed |

Zhou, Q. Y., and Meidan, R. (2008). Biological function of prokineticins. Results Probl. Cell Differ. 46, 181–199.
| CrossRef | CAS | PubMed |

Zlot, C., Ingle, G., Hongo, J., Yang, S., Sheng, Z., Schwall, R., Paoni, N., Wang, F., Peale, F. V., and Gerritsen, M. E. (2003). Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor. J. Biol. Chem. 278, 47 654–47 659.
| CrossRef | CAS |